High Expression of HLA-A2 on an Oral Squamous Cell Carcinoma with Down-Regulated Transporter for Antigen Presentation
- 1 February 2001
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 280 (4) , 1008-1014
- https://doi.org/10.1006/bbrc.2000.4234
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Synthetic insertion signal sequences enhance MHC class I presentation of a peptide from the melanoma antigen MART-1European Journal of Immunology, 2000
- Molecular Analyses of Five New Chimpanzee MHC Class I Alleles: Implications for Differences between Evolutional Mechanisms of HLA-A, -B, and -C LociBiochemical and Biophysical Research Communications, 1999
- DEGRADATION OF CELL PROTEINS AND THE GENERATION OF MHC CLASS I-PRESENTED PEPTIDESAnnual Review of Immunology, 1999
- HLA-A*0201 presents TAP-dependent peptide epitopes to cytotoxic T lymphocytes in the absence of tapasinEuropean Journal of Immunology, 1998
- Roles for Calreticulin and a Novel Glycoprotein, Tapasin, in the Interaction of MHC Class I Molecules with TAPImmunity, 1996
- Loss of HLA class I antigens by melanoma cells: molecular mechanisms, functional significance and clinial relevanceImmunology Today, 1995
- Mutation of the α2 domain disulfide bridge of the class I molecule HLA-A∗0201 Effect on maturation and peptide presentationHuman Immunology, 1994
- Natural history of HLA expression during tumour developmentImmunology Today, 1993
- HLA-A2 molecules in an antigen-processing mutant cell contain signal sequence-derived peptidesNature, 1992
- Partial purification and some properties of BB7.2 a cytotoxic monoclonal antibody with specificity for HLA-A2 and a variant of HLA-A28Human Immunology, 1981